TABLE 4

Selected tests for the effect of transposable element insertions on bristle number

MalesFemalesBoth sexesd
AmpliconaTestbN (HAH)cN (non-HAH)cSBN FcABN FcN (HAH)cN (non-HAH)cSBN FcABN FcSBN FcABN Fc
8A1537041.454.51*1807990.580.010.061.86
9A2027091.018.15**2127680.560.440.025.42*
9B1777090.488.39**1867680.430.020.003.80
11B946862.750.221026576.10*0.328.66**0.02
12B548300.004.05*598820.010.590.010.46
16A1856746.04*0.992237540.600.234.94*0.98
16B56742.134.06*37540.010.011.191.88
17A1137804.53*0.06968941.890.190.350.03
17B817807.21**1.34588940.030.523.661.70
  • *Significant at 0.01 ≤ P < 0.05, **significant at P < 0.01. SBN, sternopleural bristle number, ABN, abdominal bristle number.

  • For each type of test (A or B), amplicons are presented only when at least one of the tests is significant at P < 0.05.

  • a Amplicons across the Enhancer of split complex.

  • b Within each amplicon, considering only individuals with more than four sites assigned a genotype, putatively TE-containing (homozygous amplicon haplotype, HAH) individuals and non-TE individuals (non-HAH) are compared. A, an individual is HAH if no site shows a heterozygous genotype; otherwise, the individual is considered non-HAH. B, an individual is HAH if no site shows a heterozygous genotype, but is completely ignored if all sites show the major allele homozygote; otherwise, the individual is considered non-HAH. See materials and methods and Results for details.

  • c The number (N) of HAH and non-HAH individuals per amplicon and the F-statistic from an ANOVA on phenotype.

  • d For the factorial genotype-by-sex model, the F-statistic from the genotype term is presented. The number of individuals for each pooled-sex test is simply the sum of the number of individuals used for each of the single-sex tests.